Patients with advanced cancer often suffer from cachexia, a debilitating and complex extreme weight loss syndrome which is also associated with shorter survival times. A pragmatic randomised controlled trial was conducted to determine whether an oral nutritional supplement containing the omega-3 fatty acid eicosapentaenoic acid (EPA) was able to improve quality of life and survival times of patients with advanced solid tumour cancer in a mixed tumour cancer type population.
|Number of pages||8|
|Journal||BAOJ Palliative medicine|
|Publication status||Published - 24 Apr 2015|
Bibliographical note© 2015 Dewey A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Dewey, A., Higgins, B., Baughan, C., Stores, R., Dean, T., & Kilburn, S. (2015). Randomised controlled trial of fish oil supplement to treat cancer cachexia. BAOJ Palliative medicine, 1(1), 1-8. https://bioaccent.org/palliative-medicine/palliative-medicine02.php